Various cases of haemolysis and methaemoglobinaemia were described in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency treated with HCQ or CQ for COVID-19 [183,184,204,205,206]. This evidence concerns the gene G6PD and COVID-19.